Stock Market Stories and Insights

<div class='circular--portrait-small' style='font-weight: 700;background:#689CFD;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>SS</div>
  a day ago at Macroaxis 
By Vlad Skutelnik
It looks like Abbott Laboratories will be up for a correction faster as its share price went up 0.98% today to Strata Skin's 6.15%As many rational traders are trying to avoid healthcare space, it makes sense to outline Strata Skin Sciences a little further and understand how it stands against Abbott Laboratories and other similar entities. We are going to inspect some of the competitive aspects of both Strata and Abbott.
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:1.1em;padding-top: 10px;;'>AP</div>
  2 days ago at Macroaxis 
By Gabriel Shpitalnik
Aurinia Pharmaceuticals is scheduled to announce its earnings today. The next earnings report is expected on the 12th of November 2020. While many of us are getting excited about healthcare space, we are going to concentrate on the feasibility of locking in Aurinia. We will cover the possibilities of Aurinia Pharmaceuticals recovering given the current economic outlook.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF0000;color: #F5FFFA;font-size:1.1em;padding-top: 10px;;'>HM</div>
  2 days ago at Macroaxis 
By Achuva Shats
HTG Molecular is currently generating 1.1276% in daily expected returns and assumes 6.5971% risk (volatility on return distribution) over the 90 days horizon. While some of us are excited about healthcare space, it makes sense to summarize HTG Molecular in greater detail to make a better estimate of its risk and reward. We will summarize if the expected returns on HTG Molecular will justify its current volatility. The new HTG Molecular risk factors may impact the value of the stock as we estimate HTG Molecular as currently undervalued. The real value is approaching 0.80 per share.
<div class='circular--portrait-small' style='font-weight: 700;background:#800000;color: #F8F8FF;font-size:0.9em;padding-top: 12px;;'>CYR</div>
  a day ago at Macroaxis 
By Raphi Shpitalnik
Given the investment horizon of 90 days, CYREN is expected to generate 5.2 times more return on investment than the market. However, the company is 5.2 times more volatile than its market benchmark. It trades about 0.14 of its potential returns per unit of risk. The DOW is currently generating roughly 0.18 per unit of risk. As many adventurous traders are excited about technology space, it is only fair to outline the risk of shorting CYREN based on its current volatility spike. We will evaluate if CYREN's current volatility will continue into September. The latest CYREN risk factors may impact the value of the stock as we estimate CYREN as currently undervalued. The real value is approaching 2.16 per share.
<div class='circular--portrait-small' style='font-weight: 700;background:#347AFC;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>SM</div>
  a day ago at Macroaxis 
By Raphi Shpitalnik
SUPER MICRO COMPUTER is scheduled to announce its earnings today. As many baby boomers are still indifferent towards technology space, it makes sense to break down SUPER as a potential position. We will examine the reasons why it is still possible for the company to generate above-average margins given the current economic outlook.
<div class='circular--portrait-small' style='font-weight: 700;background:#347AFC;color: #ffffff;font-size:1.1em;padding-top: 10px;;'>MA</div>
  2 days ago at Macroaxis 
By Achuva Shats
Macerich Net Income Per Employee is projected to decrease significantly based on the last few years of reporting. The past year's Net Income Per Employee was at 131,370. The current year Average Assets is expected to grow to about 10 B, whereas Revenue Per Employee is forecasted to decline to about 1.1 M. This short post will go over Macerich as a possible investment alternative for your portfolios. We will provide a perspective on Macerich future direction.
<div class='circular--portrait-small' style='font-weight: 700;background:#000000;color: #f2f2f2;font-size:1.1em;padding-top: 10px;;'>NI</div>
  2 days ago at Macroaxis 
By Vlad Skutelnik
While some millenniums are indifferent towards technology space, it makes sense to review NETLIST INC. We will evaluate why we are still confident in anticipation of a recovery. Is NETLIST INC current valuation justified? We will cover the firm valuation to give you a better outlook on taking a position in the stock.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:1.1em;padding-top: 10px;;'>AM</div>
  3 days ago at Macroaxis 
By Achuva Shats
In general, we focus on analyzing Apyx Medical (NASDAQ:APYX) price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Apyx Medical daily price indicators and compare them against related drivers. While this unique economic environment continues, Apyx Medical may throw investors more surprises in two-three weeks. We will evaluate if Apyx Medical shares are reasonably priced going into September.
<div class='circular--portrait-small' style='font-weight: 700;background:#3b5998;color: #F0F8FF;font-size:1.1em;padding-top: 10px;;'>PP</div>
  2 days ago at Macroaxis 
By Vlad Skutelnik
Whilst many millenniums are getting more into energy space, it makes sense to sum up Par Pacific Holdings. We will evaluate why we are still confident in anticipation of a recovery. Is the firm valuation justified? I am going to cover Par Pacific Holdings perspective on valuation to give you a better outlook on taking a position in it.
<div class='circular--portrait-small' style='font-weight: 700;background:#FF6600;color: #FFFAFA;font-size:0.9em;padding-top: 12px;;'>TGN</div>
  2 days ago at Macroaxis 
By Vlad Skutelnik
TEGNA Inc is scheduled to announce its earnings today. The next earnings report is expected on the 5th of November 2020. TEGNA Average Assets are projected to decrease significantly based on the last few years of reporting. The past year's Average Assets were at 11.34 Billion. The current year Earnings Before Interest Taxes and Depreciation Amortization EBITDA is expected to grow to about 952.4 M, whereas Net Income Per Employee is forecasted to decline to about 36.2 K. While some of us are becoming more enthusiastic about communication services space, let's go over TEGNA Inc in greater detail to make a better estimate of its debt utilization. We will check if the company can maintain a respectable level of debt while minimizing operating losses.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page